Our Pricing

Your Complete Guide to Maintenance Dose Mounjaro

Published on: June 03, 2026

Understanding the maintenance dose mounjaro uk protocols is essential for achieving optimal long-term weight loss outcomes. At Cured Pharmacy, our UK-registered prescribers guide patients through every stage of tirzepatide treatment, from initial titration through to personalised maintenance dosing strategies that maximise clinical benefits whilst minimising side effects.

What Is a Maintenance Dose for Mounjaro?

A maintenance dose represents the optimal therapeutic level of tirzepatide that delivers sustained weight loss whilst remaining clinically tolerable for long-term use. Unlike initial titration phases, where doses increase every four weeks, the maintenance dose mounjaro uk prescribers recommend is typically held constant once you've reached your target therapeutic response [1].

In the SURMOUNT-1 trial, participants who reached maintenance doses of 10mg or 15mg weekly achieved average body weight reductions of 19.5% and 20.9% respectively over 72 weeks [1]. The maintenance phase generally begins after 16-20 weeks of dose escalation, though individual timelines vary based on tolerability and clinical response.

Your UK prescriber will determine your optimal maintenance dose through careful assessment of weight loss velocity, metabolic markers, and any gastrointestinal side effects experienced during titration. Some patients achieve their goals on 5mg or 7.5mg weekly, whilst others require 12.5mg or 15mg for maximal therapeutic benefit [2].

Mounjaro Dose Progression Schedule UK

The standard tirzepatide titration protocol approved by the MHRA follows a gradual four-week escalation pattern designed to optimise tolerability. All patients begin with 2.5mg weekly for the first four weeks, regardless of their eventual maintenance target [1].

After the initial month, your dose typically increases to 5mg weekly for another four weeks. If well-tolerated and weight loss is progressing satisfactorily, your UK prescriber may maintain you at 5mg as your maintenance dose, or continue escalation to 7.5mg, then 10mg, 12.5mg, and finally 15mg at four-week intervals [2].

Clinical data from the SURPASS trials demonstrate that approximately 60% of patients reach their maintenance dose mounjaro uk prescribers recommend between 10mg and 15mg weekly, whilst 25% achieve optimal results on lower doses of 5mg or 7.5mg [1]. The remaining 15% may require dose adjustments based on individual response patterns.

When to Increase Your Mounjaro Dose

Your UK prescriber will consider dose escalation if you've tolerated your current dose well for at least four weeks and weight loss has plateaued despite adherence to lifestyle modifications. Typical indicators for progression include minimal gastrointestinal side effects, consistent weekly injections, and weight loss velocity dropping below 0.5% of body weight per week [2].

Never adjust your Mounjaro dose without consulting your UK prescriber. Premature escalation increases the risk of nausea, vomiting, and treatment discontinuation, whilst staying on subtherapeutic doses may delay your weight loss goals unnecessarily.

Optimal Maintenance Dose Mounjaro UK Prescribers Recommend

The optimal maintenance dose varies significantly between individuals and depends on multiple clinical factors including baseline BMI, weight loss goals, metabolic health markers, and side effect tolerance. In clinical practice, UK prescribers most commonly maintain patients on either 10mg or 15mg weekly once titration is complete [1].

Data from the SURMOUNT-1 trial showed that patients maintained on 15mg weekly achieved the greatest absolute weight reduction, averaging 20.9% of initial body weight over 72 weeks, compared to 19.5% on 10mg and 15.0% on 5mg [1]. However, higher doses correlate with increased gastrointestinal side effects, particularly during the first 8-12 weeks at each new dose level.

Your UK prescriber at Cured Pharmacy will review your progress every 8-12 weeks during maintenance therapy, assessing weight loss trajectory, HbA1c levels if you have type 2 diabetes, and any persistent side effects. Some patients benefit from dose reduction after achieving their target weight, whilst others require sustained higher doses to maintain their losses [2].

Personalising Your Maintenance Strategy

Individual response to tirzepatide varies considerably based on genetic factors, baseline insulin resistance, gut microbiome composition, and adherence to dietary modifications. Your UK prescriber may recommend staying at a lower maintenance dose if you've achieved your weight loss goals and metabolic improvements on 7.5mg or 10mg, rather than automatically escalating to maximum doses [2].

Clinical experience shows that patients who combine Mounjaro with structured nutrition support and regular physical activity often achieve satisfactory outcomes on lower maintenance doses, reducing both treatment costs and side effect burden whilst maintaining long-term weight stability.

Managing Side Effects at Maintenance Dose

Gastrointestinal side effects typically diminish significantly once you've been on a stable maintenance dose for 4-8 weeks, as your digestive system adapts to tirzepatide's effects on gastric emptying and gut hormone signalling [3]. The most commonly reported side effects during maintenance include mild nausea (affecting approximately 18% of patients), occasional constipation (12%), and transient diarrhoea (10%) [1].

If you experience persistent nausea or vomiting at your maintenance dose mounjaro uk prescribers have established, simple dietary modifications often provide relief. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking your injection in the evening rather than morning can all reduce gastrointestinal symptoms without requiring dose reduction [3].

Serious side effects remain rare but require immediate medical attention. Contact your UK prescriber or NHS 111 if you develop severe abdominal pain (which may indicate pancreatitis), persistent vomiting leading to dehydration, visual changes, or signs of thyroid swelling. These occur in less than 1% of patients but warrant prompt clinical assessment [2].

Long-Term Maintenance and Treatment Duration

Clinical trial data for tirzepatide extends to 72 weeks, demonstrating sustained weight loss throughout this period when patients remain on their optimal maintenance dose [1]. Real-world evidence from the United States, where Mounjaro has been available since 2022, suggests that many patients continue treatment for 12-24 months or longer to maintain their weight loss achievements.

The decision to continue or discontinue maintenance dose mounjaro uk treatment should be made collaboratively with your prescriber based on several factors: achievement of weight loss goals, improvement in obesity-related comorbidities, tolerability, cost considerations, and your ability to maintain losses through lifestyle measures alone [2].

Research indicates that approximately 60-70% of weight lost during active Mounjaro treatment may be regained within 12 months of discontinuation if lifestyle modifications aren't sustained [3]. Many UK prescribers therefore recommend a gradual dose reduction strategy rather than abrupt cessation, allowing you to assess your ability to maintain weight loss on lower doses before stopping entirely.

Transitioning Off Mounjaro Maintenance

If you and your UK prescriber decide to stop Mounjaro after achieving your goals, a structured transition plan maximises your chances of maintaining your weight loss long-term. This typically involves reducing your dose by one step every 4-8 weeks whilst intensifying dietary support, increasing physical activity, and monitoring weight weekly [2].

Some patients successfully transition to lower-cost weight management medications like orlistat or maintain their losses through lifestyle measures alone, whilst others may require intermittent courses of GLP-1 therapy if weight regain occurs. Your Cured Pharmacy prescriber can discuss all maintenance options during your regular review consultations.

Getting Started with Mounjaro at Cured Pharmacy

At Cured Pharmacy, we provide genuine UK-licensed Mounjaro KwikPens with transparent upfront pricing and expert clinical support throughout your treatment journey. Our online consultation takes under three minutes to complete, and a UK-registered prescriber will review your medical history to determine if Mounjaro is clinically appropriate for you.

We supply all Mounjaro doses from the initial 2.5mg starter pens through to 15mg maintenance pens, ensuring continuity of care as you progress through titration. Each prescription includes detailed injection technique guidance, side effect management strategies, and direct access to our clinical team for any questions during your treatment.

Your Mounjaro prescription requires clinical assessment by our UK prescribers, who will evaluate your BMI, weight loss history, current medications, and any contraindications before approving treatment. We offer discreet packaging and reliable delivery across the UK, with regular follow-up consultations to optimise your maintenance dose mounjaro uk strategy for long-term success.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.